760 related articles for article (PubMed ID: 17397939)
1. In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation.
Wang Y; Wei L; Jiang D; Cong X; Fei R; Chen H; Xiao J; Wang Y
Antiviral Res; 2007 Aug; 75(2):139-45. PubMed ID: 17397939
[TBL] [Abstract][Full Text] [Related]
2. Impact of hepatitis B e antigen-suppressing mutations on the replication efficiency of entecavir-resistant hepatitis B virus strains.
Amini-Bavil-Olyaee S; Herbers U; Luedde T; Trautwein C; Tacke F
J Viral Hepat; 2011 Nov; 18(11):804-14. PubMed ID: 20887378
[TBL] [Abstract][Full Text] [Related]
3. Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B.
Erhardt A; Reineke U; Blondin D; Gerlich WH; Adams O; Heintges T; Niederau C; Häussinger D
Hepatology; 2000 Mar; 31(3):716-25. PubMed ID: 10706563
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B e antigen-suppressing mutations enhance the replication efficiency of adefovir-resistant hepatitis B virus strains.
Herbers U; Amini-Bavil-Olyaee S; Mueller A; Luedde T; Trautwein C; Tacke F
J Viral Hepat; 2013 Feb; 20(2):141-8. PubMed ID: 23301549
[TBL] [Abstract][Full Text] [Related]
5. The YMDD and rtA194T mutations result in decreased replication capacity in wild-type HBV as well as in HBV with precore and basal core promoter mutations.
Zhu Y; Curtis M; Borroto-Esoda K
Antivir Chem Chemother; 2011 Aug; 22(1):13-22. PubMed ID: 21860069
[TBL] [Abstract][Full Text] [Related]
6. Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India.
Chauhan R; Kazim SN; Bhattacharjee J; Sakhuja P; Sarin SK
J Med Virol; 2006 Aug; 78(8):1047-54. PubMed ID: 16789012
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the basic core promoter region of hepatitis B virus. Relationship with precore variants and HBV genotypes in a Spanish population of HBV carriers.
Jardi R; Rodriguez F; Buti M; Costa X; Valdes A; Allende H; Schaper M; Galimany R; Esteban R; Guardia J
J Hepatol; 2004 Mar; 40(3):507-14. PubMed ID: 15123367
[TBL] [Abstract][Full Text] [Related]
8. [Construction of whole-genome lamivudine-resistant hepatitis B virus mutant and its replication and expression in HepG2 cells].
Sun J; Wang C; Wen SJ; Wang ZH; Hou JL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):991-3. PubMed ID: 17666334
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ
J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
[TBL] [Abstract][Full Text] [Related]
10. Genetic characteristics of hepatitis B virus genotypes as a factor for interferon-induced HBeAg clearance.
Hou J; Schilling R; Janssen HL; Hansen BE; Heijtink R; Sablon E; Williams R; Lau GK; Schalm SW; Naoumov NV
J Med Virol; 2007 Aug; 79(8):1055-63. PubMed ID: 17596838
[TBL] [Abstract][Full Text] [Related]
11. Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy.
Lin CL; Liao LY; Wang CS; Chen PJ; Lai MY; Chen DS; Kao JH
Liver Int; 2004 Feb; 24(1):9-15. PubMed ID: 15101995
[TBL] [Abstract][Full Text] [Related]
12. Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants.
Tacke F; Gehrke C; Luedde T; Heim A; Manns MP; Trautwein C
J Virol; 2004 Aug; 78(16):8524-35. PubMed ID: 15280461
[TBL] [Abstract][Full Text] [Related]
13. [Construction and biological activity assessment of core mutants of hepatitis B virus adr subtype].
Chen WH; Lin YL; Wang YJ; Luo KX
Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar; 22(3):254-5. PubMed ID: 12390781
[TBL] [Abstract][Full Text] [Related]
14. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
[TBL] [Abstract][Full Text] [Related]
15. [Construction of recombinant replication competent plasmids containing HBV genome with mutations of precore and basic core promoter].
Wang Y; Jiang D; Wei L; Chen HS; Cong X; Fei R; Wang Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):218-22. PubMed ID: 15640852
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of HBV genomes from patients with fulminant hepatitis.
Sterneck M; Kalinina T; Günther S; Fischer L; Santantonio T; Greten H; Will H
Hepatology; 1998 Nov; 28(5):1390-7. PubMed ID: 9794926
[TBL] [Abstract][Full Text] [Related]
17. Relationship between HBV genotypes and anti-viral therapeutic efficacy of interferon-alpha.
Ma JC; Wang LW; Li XJ; Liao YF; Hu XY; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):166-71. PubMed ID: 17374576
[TBL] [Abstract][Full Text] [Related]
18. The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains.
Amini-Bavil-Olyaee S; Herbers U; Sheldon J; Luedde T; Trautwein C; Tacke F
Hepatology; 2009 Apr; 49(4):1158-65. PubMed ID: 19263474
[TBL] [Abstract][Full Text] [Related]
19. In vitro resistance to interferon of hepatitis B virus with precore mutation.
Wang Y; Wei L; Jiang D; Cong X; Fei R; Xiao J; Wang Y
World J Gastroenterol; 2005 Feb; 11(5):649-55. PubMed ID: 15655815
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B.
Liu CJ; Jeng YM; Chen CL; Cheng HR; Chen PJ; Chen TC; Liu CH; Lai MY; Chen DS; Kao JH
J Infect Dis; 2009 Mar; 199(5):742-9. PubMed ID: 19199543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
